 He went on to earn his Ph.D. in chemistry from the University of Rochester in 1950.Upon completion of his studies, Conover joined Pfizer's chemical research department.He was part of a team exploring the molecular architecture of the broad-spectrum antibiotics Terramycin and Aureomycin.